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INTRODUCTION
Hearing loss is the most frequent condition limiting communication between humans. It has been esti mated that approximately 70 million people worldwide have a hearing loss of at least 55 dB (Wilson, 1985) . Loss in hearing acuity of at least 25 dB has been re ported in approximately 1% of young adults and in-1 To whom correspondence should be addressed. Telephone; 323-8202570. Fax: 323-8202566.
creases markedly with age to approximately 10% at age 60 and 50% at age 75 or older (Morton, 1991) . Pro gressive hearing loss of the elderly (presbycusis) is probably due to a multifactorial interaction of genetic and environmental factors. In some cases, progressive postlingual hearing loss is monogenic, and many au tosomal dominant families with this type of hearing loss have been described (Cohen and Gorlin, 1995) . By identifying genes responsible for monogenic hearing loss, more insight may be gained into the molecular process of hearing and the pathology of hearing loss, which may help in understanding the complex multi factorial process of presbycusis.
Initially, localization of genes responsible for nonsyndromic hearing loss has been very slow. To date, how ever, 26 genes have been localized to specific autosomal regions by linkage analysis. These genes have been classified in two categories: DFNA for autosomal domi nant hearing loss and DFNB for autosomal recessive hearing loss. Nearly all DFNA families generally have progressive hearing loss that is often mild at a younger age, while most of the DFNB families have a profound congenital deafness. A list of all published loci, includ ing detailed genetic and clinical information, can be found on-line in the Hereditary Hearing Loss Home page (http://www-dnalab.uia. ac.be/dnalab/hhh/).
Recently, we mapped a gene for autosomal dominant sensorineural hearing loss starting in the high frequen cies (DFNA2) to chromosome 1 in an extended family originating from Indonesia, and we found that the same gene is responsible for hearing loss in a family from the United States (Coucke et al., 1994). Here we report three additional large families from Belgium and The Netherlands with a similar type of progressive hearing loss, linked to DFNA2. Combining the informa-tion from all five linked families, we were able to reduce the region that most likely contains the DFNA2 gene to a 1.25-Mb region between genetic markers D1S432 and MYCL1.
telomere
MATERIALS A N D M ETHODS
Clinical diagnosis. Otologic examination and pure tone audiome try with air and bone conduction were performed on every family member who participated in this study, and blood samples were taken for DNA extraction. The audiometric curves of all family mem bers were compared with age-and sex-dependent percentile curves (International Organization for Standardization, 1984). Family members were considered affected if they had a sensorineural hear ing loss with an audiometric curve below the 95th percentile (P95) of the reference curves for most frequencies for both ears. Family members were considered unaffected if hearing thresholds at most frequencies were better than 20-dB hearing level or above the 50th percentile. Normal-hearing individuals below the age of 35 for the Belgian family, below 40 for Dutch family 1, and below 25 for Dutch family 2 were given an unknown disease status in the linkage analy sis. Persons with an atypical or doubtful audiogram, or with a history of environmental factors that could be implicated in their hearing loss, were also given an unknown disease status. In a few cases, the family history of married-in individuals revealed a possible heredi tary hearing loss. These individuals and their children were also given an unknown affection status.
Belgian family. A family pedigree consisting of approximately 150 family members over 4 generations was constructed. Audiometry was performed and blood samples were obtained from 65 family members. Twenty-seven family members were diagnosed as affected. In most affected family members between 10 and 30 years of age, hearing was impaired only at frequencies above 1000 Hz. Above the age of 30, a loss below 1000 Hz generally became apparent, although this was in some cases not below the P95 of the reference curves. The average progression rate of the hearing loss in this family was much higher above 1000 Hz (between 2 and 5 dB per year) than below 1000 Hz (between 0.2 and 0.5 dB per year).
Dutch family 1. A pedigree comprising more than 250 family members in 6 generations was constructed. Eighty-eight family members were tested audiometrically, and blood samples were ob tained from all of them. Forty-one family members were diagnosed as affected. In all affected persons, a hearing loss that was most pronounced in the high frequencies and that showed a progress of approximately 1 dB per year could be demonstrated.
Dutch family 2. A pedigree of over 400 family members in 6 gen erations was reconstructed. Eighty-four of these were tested audio metrically, and blood samples were obtained from them. Twentyfour of them were diagnosed as affected. In this family a progressive hearing loss starting in the high frequencies, which was very similar to Dutch family 1, was found. Cottingham et aL, 1993) . The frequency of hearing loss due to mutations in DFNA2 was set at 1/10,000. Pene trance was set at 98%, and the chance that family members without a mutation in DFNA2 showed hearing loss was set at 2%, to allow for possible phenocopies. Recombination frequencies were assumed to be equal for males and females. For each marker the number of alleles in the lod score calculations was set at the observed number of alleles in the pedigree (A0, and allele frequencies were set equal at 1 IN, Changes in the allele frequencies resulted only in minor alterations of the two-point lod scores and did not alter the conclu sions of the study.
RESULTS

Linkage Analysis
Positive linkage to the short arm of chromosome 1 had been demonstrated previously in an Indonesian and an American family with autosomal dominant nonsyndromic progressive hearing loss (DFNA2) with markers D1S201, D1S255, D1S193, and D1S211 (Coucke et al., 1994) .
In this study we identified three additional families with a similar type of hearing loss linked to DFNA2 and analyzed two new markers from the DFNA2 region, D1S432 and MYCL1. The localization of these markers relative to the markers used in the original study is given in Fig. 1 . Two-point lod scores for MYCL1 and D1S432 in all five DFNA2 families are given in Table  1 . Positive lod scores over +3.0 were obtained for all likely lies between D1S432 and MYCL1 ( Fig. 1) ,
Key Recombinants Phenocopies
In our previous study (Coucke et aL, 1994), a 6-cM Surprisingly, one individual from the Belgian family candidate region for DFNA2 was defined between and two individuals from Dutch family 1 diagnosed markers D1S255 and D1S211. This candidate region as affected by audiometry did not inherit the disease was delineated by a single key recombinations in the haplotype from their affected parent but inherited the American family with D1S255 on its telomeric side and normal haplotype. A double recombination between by a single key recombinant in the Indonesian family DFNA2 and the two informative flanking markers with D1S211 on its centromeric side. D1S193 located D1S432 and MYCL1 is unlikely as these two markers 1 cM distal to D1S211 was uninformative in the Indo-are very closely linked. Therefore, the hearing loss in nesian recombinant. To reduce this candidate region, these three individuals most likely represents a phenothe new markers D1S432 and MYCL1 were analyzed copy. Their medical history did not disclose any enviin the key recombinants from the Indonesian and ronmental factor that might explain their hearing loss, American families. The Indonesian key recombinant and reevaluation of the audiograms revealed no misdi m t h marker D1S211 also recombines with MYCL1, lo-agnosis. Most likely, another gene or nongenetic factors calizing DFNA2 telomeric of MYCLl. Analysis of the are responsible for the hearing loss in these three paAmerican key recombinant places DFNA2 centromeric tients. In the other three families, no phenocopies were of D1S432. Both key recombinants reduce the DFNA2 found, candidate region to the interval between D1S432 and MYCLl, with a single recombinant on both sides.
Haplotype Comparison
To confirm this candidate region, the most likely dis ease haplotype for D1S255, D1S432, MYCLl, and
We investigated the possibility that some of the five D IS 193 was constructed in the three new DFNA2 fami-DFNA2 families are related to each other by comparing lies. This revealed five recombinations in the region the disease haplotypes of the five DFNA2 families. Five between D1S255 and D1S432, localizing DFNA2 cen-different linked haplotypes were found. For the two tromeric of D1S255. Four recombinations in the region closest flanking markers D1S432 and MYCLl, respecbetween D1S432 and MYCLl in Dutch family members tively four and five different linked alleles are present (three affected individuals in family 1 and one unaf-in the five families. It has been calculated that a region fected individual in family 2) localize DFNA2 centro-of 1 cM remains identical by descent between two demeric of D1S432, confirming the recombinant in the scendants of a common ancestor for more than 15 genAmerican family. Three recombinations in the region erations (meiotic count of 30) with a probability of 95% between D1S193 and MYCLl localize DFNA2 te-(te Meerman et aL, 1994). Therefore, it is unlikely that lomeric of D1S193. The Indonesian recombinant lo-any pair of the five DFNA2 families is related up to 15 calizing DFNA2 telomeric to MYCLl was not confirmed generations ago, with the exception of the Americanby other recombinants in the three new families. No Dutch 2 pair, who have the same allele for D1S432. key recombinants were present in the Belgian family. However, it is impossible to know whether the allele Combining all five DFNA2 families, a total of six key for D1S432 in these two families is identical by descent or just by chance. Overall, it is likely that most of the five DFNA2 families carry mutations in the DFNA2 gene that have arisen on separate occasions.
DISCUSSION
In this study we describe very conclusive linkage of three new families with nonsyndromic progressive hearing loss starting in the high frequencies to the DPNA2 locus on chromosome lp. These three families originate from Belgium and The Netherlands, and to gether with the Indonesian and American family that we reported earlier, they bring the total of families linked to DFNA2 to five.
Six key recombinants in these five families reduce the DFNA2 candidate region to a small interval be tween D1S432 and MYCL1. However, it must be kept in mind that only a single proximal recombinant with MYCL1 was found up to now. The possibility that this is not a true recombinational event but a phenocopy cannot be excluded, as this patient has no affected chil dren and phenocopies for this type of deafness are not uncommon. Therefore, a more conservative candidate region for DFNA2, based on at least two recombinants on each side of the DFNA2 gene, would be the 3-cM interval between D1S432 and D1S193. Highly poly morphic markers are present on both sides of this inter val, providing a very reliable predictive and diagnostic DNA test that is now available for families in which hearing loss is linked to DFNA2. Early presymptomatic diagnosis based upon DNA analysis can be important in career planning and school choice. Apart from its predictive value in young individuals at risk to develop hearing loss, the DNA test also has a confirmatory value in cases with an uncertain audiometric diagnosis. In addition, the DNA test can uncover incorrect audio metric diagnoses, as illustrated by the presence of three phenocopies in this study.
The presence of three phenocopies in these five DFNA2 families is not unexpected for two reasons. First, a total of 138 patients from these five families were included in our study. Second, hearing impair m ent of the high tones is very frequent, especially in the older population. To differentiate between hearing loss caused by DFNA2 and age-related hearing loss caused by other factors, .we have used age-and sexdependent reference curves for hearing thresholds. Fam ily members were only considered affected if they had hearing thresholds below the P95 of the curves for several frequencies. However, as 5% of the population h as a hearing threshold below the P95 threshold, applying only this criterium could lead to up to 5% phenocopies in the clinical diagnosis. Therefore, anam n estic data, such as noise exposure, and the careful comparison of the audiometric curves for all family members were also used to reduce the number of possi ble phenocopies. In case of doubt, family members were given an unknown affection status. However, even by applying these strict criteria, phenocopies can never be eliminated, as some of these phenocopies are phenotypically indistinguishable from hearing loss caused by mutations in the DFNA2 gene.
As the DFNA2 flanking markers, D1S432 and MYCL1, colocalize to the same YAC of 1.25 Mb, this region is amenable to positional cloning of the DFNA2 gene. Mycll, the mouse homologue of human MYCL1, is located on mouse chromosome 4, and a large region surrounding Mycll has syntenic homology to human chromosome lp. Therefore, the human homologues of genes located close to Mycll in the mouse, such as gap junction gene Gja5, colony-stimulating factor granulo cyte receptor Csfr, and the collagen gene Col8a2 (Cope land et al.} 1993), may be a source of candidate genes for DFNA2. Although several mouse mutations that affect hearing are located on mouse chromosome 4, none of them is located in the vicinity of Mycll (Nadeau  et aL, 1991) .
The five families linked to DFNA2 have a similar type of progressive hearing loss, starting in the high tones and progressing1 with age to include middle and lower frequencies. Nevertheless, statistical analysis of the audiograms shows significant differences in the progression rate of the hearing loss between some of the families from Western Europe (data not shown). This variability suggests allelic heterogeneity, the vari ous families having a different mutation in DFNA2, which is also confirmed by the finding of a different haplotype segregating with hearing loss in each of the five linked families. Many independent recombinations would be necessary to change the haplotypes from all these families into a single haplotype from a hypotheti cal ancestral founder chromosome. The occurrence of all these hypothetical recombinations, including a number of recombinations in the 1.25-Mb region be tween D1S432 and MYCL1, would require a large num ber of meioses. Although a common ancestor for all families can never be formally ruled out, it is more likely that different mutations have occurred in the same gene. This suggests that DFNA2 is an important gene for autosomal dominant hearing loss.
We have tested a total of 21 large families with au tosomal dominant hearing loss for linkage with DFNA2 (data not shown), and 5 of them were linked, strongly suggesting that the DFNA2 gene is frequently involved in hereditary progressive hearing loss. The type of hearing loss in the families linked to DFNA2 is similar to that of presbycusis in view of its sensorineural origin and progressive evolution first affecting the high tones. Therefore, DFNA2 might be involved in the pathogene sis of age-related hearing loss, and the DFNA2 families may serve as a model for studying mechanisms leading to presbycusis.
